What’s in a name? When it comes to Artistry Exact Fit® Beauty Balm Perfecting Primer, everything. This multi-benefit, sheer formula with SPF 35 harnesses the power of three benefits in one: it primes, perfects and hydrates.
In one simple step, Artistry Exact Fit® Beauty Balm Perfecting Primer instantly blurs imperfections and minimizes the appearance of pores for a visibly perfected complexion that looks natural, hydrated and beautiful. The single universal sheer shade prepares skin for optimal makeup application and wear, while helping to shield from harmful, aging UV rays and minimize the effects of free radicals and environmental aggressors.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7488156-amway-artistry-exact-fit-beauty-balm/
OneTouch®, a leading brand of blood glucose monitoring systems for people with diabetes, has introduced Life First™, a new North American campaign featuring music legend B.B. King and Crystal Bowersox, one of music’s most talented new artists. The ads debut on national and regional television today and will be followed by online and print ads over the next several months. The introduction of the campaign is particularly timely, since March 22 marks National Diabetes Alert Day in the U.S.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/onetouch/48943/
http://www.TheQueenOfTheCatskills.com
Going on a road trip with no predetermined destination? Waiting to get
that thunderous sound of your bike chiming in, planning that road
trip...your stop along the way should be at the Colonial B&B at
Stamford NY A cross country road trip planner will tell you that the
Colonial B&B at Stamford NY is your home away from home. Like Us on Facebook: https://www.facebook.com/TheColonialBedandBreakfastAtStamfordNY Follow us on Twitter: https://twitter.com/TheColonialBB
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, has announced additional positive data from its Phase 2 clinical trial of PV-10 for metastatic melanoma. The data, on changes in visceral and nodal metastases following chemoablation of cutaneous melanoma lesions with PV-10, was presented by Dr.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/pvct/43978/
